Showing results (191-200 of 5,668) with videos related to

Sort By:
Pageof 567
The Oncologist|August 23, 2021
Histologic Discordance Between Primary Tumor and Nodal Metastasis in Breast Cancer: Solving a Clinical Conundrum in the Era of GenomicsNicole K Yun, Jessica A Slostad, Ankur Naqib, et al.
The Oncologist|June 16, 2020
Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?Geok Hoon Lim, Mihir Gudi, Sze Yiun Teo, et al.
The Oncologist|May 6, 2020
Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M MutationRan Huo, Jinghua Li, Xiaofang Li, et al.
The Oncologist|August 19, 2022
FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaNajat Bouchkouj, Xue Lin, Xiaofei Wang, et al.
The Oncologist|December 14, 2004
Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?Louis Harrison, Kimberly Blackwell
The Oncologist|May 28, 2004
Monoclonal antibodies, small molecules, and vaccines in the treatment of breast cancerFrancisco J Esteva
The Oncologist|November 25, 2004
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trialF Anthony Greco, Gladys I Rodriguez, Don W Shaffer, et al.
The Oncologist|November 25, 2004
The past decade of experience with isolated hepatic perfusionAmelia Grover, H Richard Alexander
The Oncologist|November 25, 2004
Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapyCharles L Vogel, Ronald H Yanagihara, Albert J Wood, et al.
The Oncologist|November 25, 2004
A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancerLee S Schwartzberg, Lorrin K Yee, Frank M Senecal, et al.
Pageof 567